naltrexone depot
Pre-clinical- Indications
- Alcohol dependence
Company intelligence / Profile preview
DrugAbuse Sciences, Inc.
Los Altos, California, USAdrugabusesciences.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
DrugAbuse Sciences developed a portfolio of medications targeting alcohol and substance abuse. Its lead product was Naltrexone Depot, a long‑acting injectable formulation for alcohol dependence that reached Phase III clinical trials. Other programs included NALTREL™ for heroin dependence in preparation for Phase III trials; DAS‑431™ IV, a dopamine D1 agonist in Phase II for cognitive impairment and CNS diseases; plus several preclinical candidates including Buprenorphine Depot, COC‑AB™, and ITAC™[1][2].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- small molecules (e.g., naltrexone formulations)depot/injectable formulations (e.g., Naltrexone Depot)dopamine receptor agonists (e.g., DAS‑431™ IV)buprenorphine depot formulations (preclinical)antibody-based therapies (COC‑AB™, preclinical)immunotherapies/vaccines (ITAC™, preclinical)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on DrugAbuse Sciences, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DrugAbuse Sciences, Inc..